Abstract:BACKGROUND:The pathogenesis of severe hepatitis B remains unknown. Reports have indicated that hepatitis B virus (HBV) mutations are important factors in the pathogenesis of this disease. This study was to investigate the genetic heterogeneity of HBV strains from serum samples of patients with fulminant hepatitis B.METHODS:Full-length HBV genomes from 4 patients with severe hepatitis B were cloned and sequenced to observe mutations in every open reading-frame (ORF). Serum samples of another 25 patients with severe hepatitis B, 30 patients with chronic hepatitis B, and 25 HBV carriers were collected for sequencing and comparison of mutations in preS2, preC and core promoter regions.RESULTS:Of 4 HBV full-length genome sequences, 3 had a G to A mutation at nucleotide A1896 in the preC region and 1 had double mutations of T1762-A1764 in the core promoter region. The 4 sequences showed mutations in the known B or T cell epitopes of the preS2 and C regions. For the other 3 groups, more mutations were seen in the preS2 region in the HBV isolates from the patients with severe hepatitis B than those from the patients with chronic hepatitis B and HBV carriers (P<0.01). There was a significant difference of mutations in the T cell epitope region of preS2 between the patients with severe hepatitis B and those with chronic hepatitis B or HBV carriers (P<0.01). In the preC and core promoter regions, the mutation frequencies of T1653 and C1753 were 48.0% and 24.0% respectively in the patients with severe hepatitis B, but none of these mutations were observed in the patients with chronic hepatitis B group or HBV carriers (P<0.01). The mutation frequency of T1762-A1764 was 76.0% in the patients with severe hepatitis B, 40.0% in the patients with chronic hepatitis B (P<0.01), and 16.0% in the HBV carriers (P<0.01). There was a significant difference in A1896 mutation between the patients with severe hepatitis B and the patients with chronic hepatitis B (P<0.05) or the HBV carriers (P<0.05).CONCLUSION:Our observations suggest that the accumulation and persistence of high frequency mutations or complex mutations may be associated with the development and deterioration of HBV infection.

A336C/A336T/T337C variations in HBV core gene and spontaneous hepatitis B e antigen loss in chronic hepatitis B patients

[Relationship between the quantitative results of HBV DNA and HBV markers (HBV M) in population with low-level HBsAg].

Detecting of the Hepatic Fibrotic Indexes and Serous Markers from Patients with Chronic Hepatitis B (chb)and Variation of HBV DNA YMDD

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

The Frequency and Skewed T-Cell Receptor Beta-Chain Variable Patterns of Peripheral Cd4(+)Cd25(+) Regulatory T-Cells Are Associated with Hepatitis B E Antigen Seroconversion of Chronic Hepatitis B Patients During Antiviral Treatment

Study on the Correlation Between a Set of Single Nucleotide Polymorphisms of Hepatitis B Virus Core Gene and Serum HBV DNA Levels in Patients with Chronic Hepatitis B

Hepatitis B Virus Basal Core Promoter Mutations A1762T/G1764A Are Associated with Genotype C and a Low Serum HBsAg Level in Chronically-Infected HBeAg-positive Chinese Patients.

Higher Lifetime Chance of Spontaneous Surface Antigen Loss in Hepatitis B Carriers with Genotype C Infection.

Clinical significance of a set of single nucleotide polymorphisms of hepatitis B virus core gene in Chinese Han patients with chronic hepatitis B.

Naturally Occurring Hepatitis B Surface Gene Variants in Chronic Hepatitis B Virus Infection: Correlation with Viral Serotypes and Clinical Stages of Liver Disease

Correlation of Hepatitis B Virus (hbv) Genotypes and Mutations in Basal Core Promoter/Precore with Clinical Features of Chronic Hbv Infection

Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase

Association of Genetic Polymorphisms in Cd8+T Cell Inhibitory Genes and Susceptibility to and Progression of Chronic Hbv Infection

Prevalence of Basal Core Promoter and Precore Mutations in Chinese Chronic Hepatitis B Patients and Correlation with Serum HBeAG Titers

High Level of Hepatitis B Virus DNA after HBeAg-to-anti-HBe Seroconversion is Related to Coexistence of Mutations in Its Precore and Basal Core Promoter

Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.

Hepatitis B Virus Genotype B with G1896A and A1762T/G1764A Mutations is Associated with Hepatitis B Related Acute‐on‐chronic Liver Failure

Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy.

Association Of Hepatitis B Virus Basal Core Promoter T1762/A1764 And Precore A1896 Mutations With Serum Hepatitis B Virus Dna Load, Hepatitis B E Antigen Status, Serum Alpha-Fetoprotein And Hepatitis B Virus-Related Liver Disease Progression